|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Capitalization1 |
16 230 | 14 091 | 18 213 | 21 371 | 22 913 | - |
| Entreprise Value (EV)1 |
17 439 | 15 275 | 18 813 | 26 275 | 26 999 | 26 004 |
| P/E ratio |
20,8x | 20,4x | 21,8x | 22,8x | 22,8x | 20,3x |
| Yield |
1,72% | 1,96% | 1,74% | 1,54% | 1,46% | 1,65% |
| Capitalization / Revenue |
1,27x | 1,07x | 1,29x | 1,35x | 1,36x | 1,29x |
| EV / Revenue |
1,36x | 1,16x | 1,33x | 1,66x | 1,60x | 1,47x |
| EV / EBITDA |
9,72x | 7,99x | 8,23x | 10,4x | 10,4x | 9,30x |
| Price to Book |
2,39x | 1,94x | 2,15x | 3,28x | 3,20x | 2,90x |
| Nbr of stocks (in thousands) |
164 118 | 162 341 | 167 244 | 168 538 | 168 538 | - |
| Reference price (EUR) |
98,9 | 86,8 | 109 | 127 | 136 | 136 |
| Last update |
02/15/2018 | 02/14/2019 | 02/13/2020 | 02/17/2021 | 02/25/2021 | 02/25/2021 |
|
1 EUR in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net sales1 |
12 792 | 13 197 | 14 125 | 15 848 | 16 880 | 17 750 |
| EBITDA1 |
1 794 | 1 912 | 2 286 | 2 527 | 2 600 | 2 797 |
| Operating profit (EBIT)1 |
1 493 | 1 597 | 1 741 | 1 879 | 2 064 | 2 236 |
| Operating Margin |
11,7% | 12,1% | 12,3% | 11,9% | 12,2% | 12,6% |
| Pre-Tax Profit (EBT)1 |
1 111 | 1 171 | 1 354 | 1 355 | 1 508 | 1 747 |
| Net income1 |
820 | 730 | 856 | 957 | 971 | 1 160 |
| Net margin |
6,41% | 5,53% | 6,06% | 6,04% | 5,75% | 6,54% |
| EPS2 |
4,76 | 4,25 | 5,00 | 5,55 | 5,96 | 6,69 |
| Dividend per Share2 |
1,70 | 1,70 | 1,90 | 1,95 | 1,99 | 2,25 |
| Last update |
02/15/2018 | 02/14/2019 | 02/13/2020 | 02/17/2021 | 03/03/2021 | 03/03/2021 |
|
1 EUR in Million 2 EUR Estimates
|
|
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net Debt1 |
1 209 | 1 184 | 600 | 4 904 | 4 086 | 3 092 |
| Net Cash position1 |
- | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
0,67x | 0,62x | 0,26x | 1,94x | 1,57x | 1,11x |
| Free Cash Flow1 |
1 104 | 1 160 | 1 288 | 1 119 | 1 396 | 1 608 |
| ROE (Net Profit / Equities) |
14,7% | 10,1% | 10,8% | 13,2% | 17,7% | 17,9% |
| Shareholders' equity1 |
5 577 | 7 218 | 7 952 | 7 263 | 5 471 | 6 485 |
| ROA (Net Profit / Asset) |
6,44% | 4,50% | 4,94% | 4,77% | 5,16% | 5,73% |
| Assets1 |
12 738 | 16 221 | 17 317 | 20 044 | 18 827 | 20 255 |
| Book Value Per Share2 |
41,4 | 44,8 | 50,7 | 41,5 | 42,5 | 46,8 |
| Cash Flow per Share2 |
7,73 | 8,13 | 10,8 | 9,91 | 10,4 | 11,3 |
| Capex1 |
226 | 229 | 219 | 204 | 279 | 269 |
| Capex / Sales |
1,77% | 1,74% | 1,55% | 1,29% | 1,65% | 1,52% |
| Last update |
02/15/2018 | 02/14/2019 | 02/13/2020 | 02/17/2021 | 02/25/2021 | 02/25/2021 |
|
1 EUR in Million 2 EUR Estimates
|
|
|
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Capgemini : Insurers rewrite business policies after pandemic legal tussles |
Capitalization (EUR) 22 912 748 849 Capitalization (USD) 27 176 786 679 Net sales (EUR) 14 125 000 000 Net sales (USD) 16 734 735 000 Number of employees 269 800 Sales / Employee (EUR) 52 354 Sales / Employee (USD) 62 026 Free-Float capitalization (EUR) 21 542 307 389 Free-Float capitalization (USD) 25 551 307 542 Avg. Exchange 20 sessions (EUR) 60 452 771 Avg. Exchange 20 sessions (USD) 71 622 025 Average Daily Capital Traded 0,26%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
